drugset / Trial / NCT00681525
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to evaluate the potential PK interaction between ABT-335, atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-335 | Small molecule | 135 mg | — |
| Subject | Atorvastatin | Small molecule | 80 mg | — |
| Subject | Ezetimibe | Unknown | 10 mg | — |
Indications
No indication recorded.